Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma
In conclusion, HAIC combined with lenvatinib and PD-1 blockade yields better tumor control and survival outcomes over SC for unresectable iCCA, with manageable adverse events as well.
Authors
- Bei Wu (ORCID: https://orcid.org/0000-0002-2772-1065)
- Bin Leng (ORCID: https://orcid.org/0009-0007-5370-342X)
- LU Ya (ORCID: https://orcid.org/0000-0002-3536-4424)
- Hao Jiang (ORCID: https://orcid.org/0000-0002-1182-8132)
- Qingyu Xu (ORCID: https://orcid.org/0000-0003-2281-4454)
- Chendong Wang (ORCID: https://orcid.org/0000-0002-8334-0232)
- Ran You (ORCID: https://orcid.org/0000-0003-3852-5569)
- Lingfeng Diao
- Guowen Yin
- Zeyu Yu (ORCID: https://orcid.org/0009-0003-1100-7953)
Institutions
- Jiangsu Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1007/s12672-025-02397-3
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01